31 results
424B5
NUVL
Nuvalent, Inc.
17 Sep 24
Prospectus supplement for primary offering
4:13pm
include PFS based on investigator’s assessment, and BICR assessment of ORR, IC-ORR, overall survival (OS), and safety.
NVL-330
Our third product … .
Discovery Programs
We have prioritized a number of additional small molecule research programs following an assessment of medical need. Research
424B5
NUVL
Nuvalent, Inc.
16 Sep 24
Prospectus supplement for primary offering
7:16am
on investigator’s assessment, and BICR assessment of ORR, IC-ORR, overall survival (OS), and safety.
NVL-330
Our third product candidate, NVL-330 … have prioritized a number of additional small molecule research programs following an assessment of medical need. Research for these programs
8-K
EX-99.1
NUVL
Nuvalent, Inc.
16 Sep 24
Other Events
6:05am
Independent Central Review (BICR). Secondary endpoints include PFS based on investigator’s assessment, and BICR assessment of objective response rate
424B5
5crr mg63j
17 Oct 23
Prospectus supplement for primary offering
4:05pm
424B5
9r9i11zbt
16 Oct 23
Prospectus supplement for primary offering
7:39am
8-K
EX-99.1
636dh0we1j58
13 Oct 23
Nuvalent Reports Preliminary Phase 1 Clinical Data from ALKOVE-1 Trial
6:40am
424B5
stslq9q
1 Nov 22
Prospectus supplement for primary offering
5:17pm
424B5
qb37o8k
31 Oct 22
Prospectus supplement for primary offering
7:21am
8-K
EX-99.1
7bkd55e xh
28 Oct 22
Other Events
6:05am
8-K
9z5gvrbpnd158iw1u
28 Oct 22
Other Events
6:05am
S-3
2jbonqs9856ozyk
10 Aug 22
Shelf registration
8:35am
S-3
EX-4.4
zk674k97la 8f4fdz8ga
10 Aug 22
Shelf registration
8:35am
S-3
EX-4.5
wqzhdi f7aqcxz
10 Aug 22
Shelf registration
8:35am